Pharmacokinetics of nasally administered tobramycin and colistin in Cystic Fibrosis

Trial Profile

Pharmacokinetics of nasally administered tobramycin and colistin in Cystic Fibrosis

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2015

At a glance

  • Drugs Tobramycin (Primary) ; Colistin
  • Indications Bacterial infections; Cystic fibrosis
  • Focus Pharmacokinetics
  • Acronyms SPOEL
  • Most Recent Events

    • 10 Nov 2015 Status changed from not yet recruiting to completed as per results published in Journal of Antimicrobial Chemotherapy
    • 12 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top